Developing a Dissociative Nanocontainer for Peptide Drug Delivery

  title={Developing a Dissociative Nanocontainer for Peptide Drug Delivery},
  author={Patrick Kelly and Prachi Anand and Alexander Uvaydov and Srinivas V. S. Chakravartula and Chhime Sherpa and Elena Pires and Alison O'Neil and Trevor Douglas and Mand{\"e} Holford},
  journal={International Journal of Environmental Research and Public Health},
  pages={12543 - 12555}
The potency, selectivity, and decreased side effects of bioactive peptides have propelled these agents to the forefront of pharmacological research. Peptides are especially promising for the treatment of neurological disorders and pain. However, delivery of peptide therapeutics often requires invasive techniques, which is a major obstacle to their widespread application. We have developed a tailored peptide drug delivery system in which the viral capsid of P22 bacteriophage is modified to serve… 
Protein Nanoparticles: Promising Platforms for Drug Delivery Applications.
This review, while focusing on a few proteins such as the silk protein fibroin, attempts to provide an overview of the existing protein-based nanoparticles and brings forth some of the factors that are important for the design of this class of nanoparticles.
Induced Disassembly of a Virus-Like Particle under Physiological Conditions for Venom Peptide Delivery
This work implements and evaluates a ring-opening metathesis polymerization (ROMP) general mechanism for controllable VLP disassembly that is independent of cell-specific factors or the manipulation environmental conditions such as pH and temperature that cannot be readily controlled in vivo.
Induced Disassembly of a Virus-like Particle under Physiological Conditions for Venom Peptide Delivery.
This work implements and evaluates a general mechanism, based on ring-opening metathesis polymerization (ROMP), for controllable VLP disassembly, which does not depend on the particular structure or morphology of the P22 nanocontainer and is adaptable to other VLP prototypes for the potential delivery of venom peptides for pharmacological applications.
Virus‐like particles: Next‐generation nanoparticles for targeted therapeutic delivery
The potential for viral capsids as noninfectious protein‐based NPs—termed virus‐like particles (VLPs) to become highly effective delivery vehicles that overcome the many challenges encountered for targeted delivery of therapeutic cargo is outlined.
Biological Assembly of Modular Protein Building Blocks as Sensing, Delivery, and Therapeutic Agents.
Key attributes of these designer protein nanostructures, their unique functions, and their impact on biosensing and therapeutic applications are discussed.
Virus Like Particles (VLPs) as a Platform for Hierarchical Compartmentalization.
This approach could be used as a model to create synthetic protein-based protocells that can confine smaller functionalized proto-organelles and additional macromolecules to support a range of biochemical reactions.
Purification, profiling and bioengineering of extracellular vesicles
This thesis explores and advances some of the challenges encountered in the EV field by ameliorating the EV isolation workflow in terms of time and scalability, linking the vesicular transcriptome and proteome of EVs derived from various cell lines, and systematically comparing and quantifying the sorting efficiency of different proteins into EVs.
Design and Applications of Protein-Cage-Based Nanomaterials.
In this review, the most commonly used viral and non-viral protein cages, which exhibit a wide diversity of size, functionality, and chemical and thermal stabilities, are described.
From Mollusks to Medicine: A Venomics Approach for the Discovery and Characterization of Therapeutics from Terebridae Peptide Toxins
While the research focuses on terebrids, the venomics approach outlined here can be applied to the discovery and characterization of peptide toxins from any venomous taxa.


Tailored delivery of analgesic ziconotide across a blood brain barrier model using viral nanocontainers
This work demonstrates proof in principle for developing a possible alternative to intrathecal injection of ziconotide using a tunable VLP drug delivery nanocontainer to cross the BBB.
Trends and developments in liposome drug delivery systems.
  • T. Lian, R. Ho
  • Biology, Chemistry
    Journal of pharmaceutical sciences
  • 2001
Detailed refinements of biomembrane sensors and liposome delivery systems that are effective in the presence of other membrane-bound proteins in vivo may permit selective delivery of therapeutic compounds to selected intracellular target areas.
Functionalization of protein-based nanocages for drug delivery applications.
This review aims to give an overview of different types of modifications of protein-based nanocontainers for drug delivery applications.
Peptide therapeutics: targeting the undruggable space.
  • N. Tsomaia
  • Biology, Chemistry
    European journal of medicinal chemistry
  • 2015
Stimuli-responsive nanocarriers for drug delivery.
Recent advances in the design of nanoscale stimuli-responsive systems that are able to control drug biodistribution in response to specific stimuli, either exogenous (variations in temperature, magnetic field, ultrasound intensity, light or electric pulses) or endogenous (changes in pH, enzyme concentration or redox gradients).
Virus-based nanocarriers for drug delivery.
Biodistribution studies of protein cage nanoparticles demonstrate broad tissue distribution and rapid clearance in vivo
In naïve and immunized mice both protein cage based nanoparticles show similar broad distribution and movement throughout most tissues and organs, rapid excretion, the absence of long term persistence within mice tissue and organ, and no overt toxicity after a single injection.
Synthesis and cell adhesive properties of linear and cyclic RGD functionalized polynorbornene thin films.
The results presented here will serve to guide future efforts for the design of RGD functionalized materials with applications in surgery, tissue engineering, and regenerative medicine.